AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by García-Ferrer, L.
Right arrow Articles by Hervas, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Ferrer, L.
Right arrow Articles by Hervas, V.
DOI:10.2214/AJR.07.3045
AJR 2008; 190:949-955
© American Roentgen Ray Society

Original Research

MRI of Mandibular Osteonecrosis Secondary to Bisphosphonates

Luis García-Ferrer1, Jose V. Bagán2, Vicente Martínez-Sanjuan3, Sergio Hernandez-Bazan2, Raquel García3, Yolanda Jiménez-Soriano2 and Vicente Hervas1

1 Department of Radiology, Consorcio Hospital General, Universitario de Valencia, Valencia, Spain.
2 Department of Stomatology, Consorcio Hospital General, Universitario de Valencia, Valencia, Spain.
3 CT and MR ERESA Unit, Consorcio Hospital General, Universitario de Valencia, Avida. Tres Cruces s/n, Valencia, Valencia, Spain 46014.

OBJECTIVE. Bisphosphonates are a group of drugs used in the treatment of oncology patients with bone metastases. However, in the past few years, osteonecrosis of the jaw has been reported as a serious complication of such treatment. The objective of this study was to examine the use of MRI in the assessment of bone lesions caused by this disease.

MATERIALS AND METHODS. Fourteen patients were studied who had been treated with IV bisphosphonates and had developed focal lesions of osteonecrosis of the jaw. These patients were referred by the stomatology department of Hospital General Universitario de Valencia. We evaluated both the morphology and the behavior of the lesions in T1, STIR, and after the administration of gadolinium.

RESULTS. Twenty-six focal lesions were detected clinically and 36 were detected radiologically. All the clinically detected focal lesions were visible on MRI. There were 15 focal lesions detected radiologically that were not detected on clinical examination. In all patients, it was possible to assess bone involvement and involvement of the bone marrow, soft tissues, sinuses, and mandibular canal as well as the presence of adenopathy.

CONCLUSION. MRI is an effective tool in the assessment of osteonecrosis of the jaw. The significance of focal lesions detectable on radiologic examination but without clinical correlation and their progression over time remains to be determined.

Keywords: bisphosphonates • jaw • MRI • osteonecrosis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.